Anika Therapeutics Inc Presenting at UBS Global Healthcare Virtual Conference Transcript
Okay. Great. Good morning, everyone. Thanks for joining us on the second day of the UBS Healthcare Conference. My name is Young Li from UBS' U.S. Medical Devices and Devices Team (sic) [U. S. Medical Supplies and Devices Team].
For this session, I'm pleased to be joined by management from Anika Therapeutics, including Dr. Cheryl Blanchard, President and CEO; and Mike Levitz, EVP, CFO and Treasurer.
Just to kick things off for this session, we're going to have some slides from Anika, followed by Q&A. (Operator Instructions)
So Cheryl and Mike, thanks so much for joining us. Really appreciate your time today. I'll turn over the floor to you.
Great. Thanks, Young, and thanks to UBS for the invitation to present today and have some time for Q&A so that we can tell Anika's story. Let me just remind everybody of our safe harbor statement, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |